# LT Vaccine Patch Self-Administration Study

> **NCT00565461** · PHASE2 · COMPLETED · sponsor: **Intercell USA, Inc.** · enrollment: 160 (actual)

## Conditions studied

- Prevention of Travelers' Diarrhea

## Interventions

- **BIOLOGICAL:** heat-labile enterotoxin of E. coli (LT)

## Key facts

- **NCT ID:** NCT00565461
- **Lead sponsor:** Intercell USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565461, "LT Vaccine Patch Self-Administration Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00565461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*